105 related articles for article (PubMed ID: 7341289)
1. Cultivation of second and third passage cells from Cercopithecus monkey kidneys in monolayer cultures.
Petersen I; Ladefoged P
Dev Biol Stand; 1981; 50():141-4. PubMed ID: 7341289
[TBL] [Abstract][Full Text] [Related]
2. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
[TBL] [Abstract][Full Text] [Related]
3. Influence of culture passages on growth kinetics and adenovirus vector production for gene therapy in monolayer and suspension cultures of HEK 293 cells.
Park MT; Lee MS; Kim SH; Jo EC; Lee GM
Appl Microbiol Biotechnol; 2004 Oct; 65(5):553-8. PubMed ID: 15168091
[TBL] [Abstract][Full Text] [Related]
4. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
Montagnon BJ; Fanget B; Nicolas AJ
Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
[TBL] [Abstract][Full Text] [Related]
5. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
[TBL] [Abstract][Full Text] [Related]
6. Killed poliovaccine: an evaluation of safety testing.
van Steenis G; van Wezel AL
Dev Biol Stand; 1981; 47():143-50. PubMed ID: 6262145
[TBL] [Abstract][Full Text] [Related]
7. Present state and developments in the production of inactivated poliomyelitis vaccine.
van Wezel AL
Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
[TBL] [Abstract][Full Text] [Related]
8. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
[TBL] [Abstract][Full Text] [Related]
9. WHO activities towards the three Rs in the development and control of biological products.
Milstien J; Grachev V; Padilla A; Griffiths E
Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
[TBL] [Abstract][Full Text] [Related]
10. An enzyme-linked immunosorbent assay, ELISA, for SV40 antigen detection.
Edevåg G; Grandien M; Mares I
J Virol Methods; 1985 Aug; 11(4):347-55. PubMed ID: 2997255
[TBL] [Abstract][Full Text] [Related]
11. Cell viability and prostacyclin release in cultured human umbilical vein endothelial cells.
Rodriguez-Morata A; Garzon I; Alaminos M; Garcia-Honduvilla N; Sanchez-Quevedo MC; Bujan J; Campos A
Ann Vasc Surg; 2008; 22(3):440-8. PubMed ID: 18466822
[TBL] [Abstract][Full Text] [Related]
12. Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.
Hilleman MR
Dev Biol Stand; 1998; 94():183-90. PubMed ID: 9776239
[TBL] [Abstract][Full Text] [Related]
13. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
[TBL] [Abstract][Full Text] [Related]
14. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous contamination of primary green monkey kidney cell cultures by foamy virus].
Mironova LL; Preobrazhenskaia NK; Kniaginskaia IuG; Belova AG
Vopr Virusol; 1980; (3):327-30. PubMed ID: 6254265
[TBL] [Abstract][Full Text] [Related]
16. Vaccine could not have been prepared in Stanleyville.
Osterrieth PM
Philos Trans R Soc Lond B Biol Sci; 2001 Jun; 356(1410):839. PubMed ID: 11405929
[TBL] [Abstract][Full Text] [Related]
17. Development of inactivated poliovirus vaccine derived from Sabin strains.
Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
[TBL] [Abstract][Full Text] [Related]
18. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
Rizzo P; Di Resta I; Powers A; Ratner H; Carbone M
Cancer Res; 1999 Dec; 59(24):6103-8. PubMed ID: 10626798
[TBL] [Abstract][Full Text] [Related]
19. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
20. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
Furesz J; Contreras G
Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
